2014 Q2 Form 10-Q Financial Statement

#000114420414031833 Filed on May 19, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $351.3K $374.9K $615.2K
YoY Change -55.77% -39.07% -13.45%
Cost Of Revenue $313.9K $210.5K $564.9K
YoY Change -50.02% -62.73% 5.58%
Gross Profit $37.40K $164.3K $50.27K
YoY Change -77.5% 226.87% -71.39%
Gross Profit Margin 10.65% 43.84% 8.17%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $60.00K $54.32K $57.08K
YoY Change 20.0% -4.83% 42.71%
% of Gross Profit 160.45% 33.06% 113.55%
Operating Expenses $1.531M $1.528M $1.271M
YoY Change -5.2% 20.19% 32.35%
Operating Profit -$1.494M -$1.363M -$1.221M
YoY Change 3.1% 11.68% 55.57%
Interest Expense $119.9K $56.00K $18.73K
YoY Change 291.22% 199.01% 78.55%
% of Operating Profit
Other Income/Expense, Net -$79.20K -$42.17K -$35.42K
YoY Change 36.36% 19.05% 239.59%
Pretax Income -$1.573M -$1.406M -$1.256M
YoY Change 4.38% 11.89% 57.99%
Income Tax $15.88K $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.589M -$1.406M -$1.256M
YoY Change 5.43% 11.89% 57.99%
Net Earnings / Revenue -452.3% -374.95% -204.19%
Basic Earnings Per Share -$0.06 -$0.05
Diluted Earnings Per Share -$59.22K -$52.73K -$57.43K
COMMON SHARES
Basic Shares Outstanding 26.78M shares 26.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $670.0K $910.0K $1.710M
YoY Change -53.47% -46.78% 194.83%
Cash & Equivalents $673.6K $914.8K $1.707M
Short-Term Investments
Other Short-Term Assets $1.280M $426.9K $1.510M
YoY Change 217.93% -71.73% 331.43%
Inventory $530.0K $394.4K $160.0K
Prepaid Expenses
Receivables $470.0K $354.9K $690.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.950M $3.193M $4.070M
YoY Change -25.61% -21.55% 92.59%
LONG-TERM ASSETS
Property, Plant & Equipment $584.9K $558.3K $481.0K
YoY Change 21.49% 16.08% -11.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $410.0K $388.5K $110.0K
YoY Change 310.0% 253.14% -90.31%
Total Long-Term Assets $1.139M $1.088M $1.588M
YoY Change -28.02% -31.44% -5.28%
TOTAL ASSETS
Total Short-Term Assets $2.950M $3.193M $4.070M
Total Long-Term Assets $1.139M $1.088M $1.588M
Total Assets $4.089M $4.281M $5.658M
YoY Change -26.29% -24.33% 49.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.090M $2.255M $1.970M
YoY Change 19.05% 14.46% 106.23%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $460.0K $522.5K $450.0K
YoY Change 4.77% 16.11% 0.0%
Long-Term Debt Due $110.0K $140.0K $70.00K
YoY Change -45.0% 100.0% 600.0%
Total Short-Term Liabilities $2.880M $3.101M $2.840M
YoY Change 15.56% 9.18% 39.73%
LONG-TERM LIABILITIES
Long-Term Debt $3.310M $1.846M $50.00K
YoY Change 3210.0% 3592.44% 400.0%
Other Long-Term Liabilities $160.0K $120.0K
YoY Change
Total Long-Term Liabilities $3.470M $1.846M $50.00K
YoY Change 3370.0% 3592.44% 400.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.880M $3.101M $2.840M
Total Long-Term Liabilities $3.470M $1.846M $50.00K
Total Liabilities $6.360M $4.947M $2.890M
YoY Change 144.62% 71.18% 41.62%
SHAREHOLDERS EQUITY
Retained Earnings -$24.80M -$23.21M
YoY Change 39.59%
Common Stock $22.46M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.269M -$783.9K $2.770M
YoY Change
Total Liabilities & Shareholders Equity $4.089M $4.281M $5.660M
YoY Change -26.29% -24.36% 49.36%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$1.589M -$1.406M -$1.256M
YoY Change 5.43% 11.89% 57.99%
Depreciation, Depletion And Amortization $60.00K $54.32K $57.08K
YoY Change 20.0% -4.83% 42.71%
Cash From Operating Activities -$1.720M -$1.512M -$170.0K
YoY Change -1.15% 789.37% -44.28%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K $137.1K $16.66K
YoY Change 40.0% 723.3% -91.81%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$70.00K -$137.1K -$20.00K
YoY Change 40.0% 585.65% -90.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $2.708M
YoY Change -100.0% 4413.62%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.550M $2.009M 1.780M
YoY Change 1.97% 12.89% 680.13%
NET CHANGE
Cash From Operating Activities -1.720M -$1.512M -170.0K
Cash From Investing Activities -70.00K -$137.1K -20.00K
Cash From Financing Activities 1.550M $2.009M 1.780M
Net Change In Cash -240.0K $360.3K 1.590M
YoY Change -11.11% -77.34% -667.24%
FREE CASH FLOW
Cash From Operating Activities -$1.720M -$1.512M -$170.0K
Capital Expenditures -$70.00K $137.1K $16.66K
Free Cash Flow -$1.650M -$1.649M -$186.7K
YoY Change -2.37% 783.48% -63.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
914834 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
559729 USD
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1101740 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1160688 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
354927 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
372587 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21801790 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
-783924 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
521809 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4281313 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3679246 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
394427 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
331437 USD
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
426935 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
295205 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
3192863 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
2719646 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
558331 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
471182 USD
CY2014Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
141666 USD
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
146666 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
388453 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
341752 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
530119 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
488418 USD
CY2014Q1 us-gaap Assets
Assets
4281313 USD
CY2013Q4 us-gaap Assets
Assets
3679246 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2254902 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2358702 USD
CY2014Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
100000 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
100000 USD
CY2014Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
522517 USD
CY2013Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
60291 USD
CY2014Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
83876 USD
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
39804 USD
CY2014Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
139556 USD
CY2013Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
164156 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3100851 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2722953 USD
CY2014Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1846218 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
364370 USD
CY2014Q1 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
118168 USD
CY2013Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
70114 USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
268 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
267 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
22455637 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
22354002 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32471 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-30670 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23207358 USD
CY2014Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong><u>Concentrations</u></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Substantially all cash is deposited in two financial institutions, one in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> million. At times, amounts on deposit in Taiwan may be in excess of the CDIC insurance limit.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Accounts receivable are unsecured, and the Company is at risk to the extent such amount becomes uncollectible. The Company performs periodic credit evaluations of its customers&#8217; financial condition and generally does not require collateral. Revenue from two customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 51</font>% of total revenues for the three months ended March 31, 2014, and approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 78</font>% of total accounts receivable at March 31, 2014.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong><u>Reclassification</u></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Certain amounts in 2013 may have been reclassified to conform to the 2014 presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26778357 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26722012 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26778357 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26722012 shares
CY2013Q1 ivda Equipment Sales
EquipmentSales
435833 USD
CY2014Q1 ivda Equipment Sales
EquipmentSales
210311 USD
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
169009 USD
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
158801 USD
CY2013Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
10380 USD
CY2014Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
5752 USD
CY2013Q1 us-gaap Revenues
Revenues
615222 USD
CY2014Q1 us-gaap Revenues
Revenues
374864 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
564948 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
210534 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
50274 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
164330 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1220809 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1363401 USD
CY2013Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-189 USD
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2234 USD
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
18730 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
56004 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35419 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42167 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1256228 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1405568 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-1256228 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
480973 USD
CY2013Q1 ivda Additions Non Current Assets
AdditionsNonCurrentAssets
16656 USD
CY2014Q1 ivda Additions Non Current Assets
AdditionsNonCurrentAssets
137129 USD
CY2013Q1 us-gaap Inventory Gross
InventoryGross
161311 USD
CY2014Q1 us-gaap Inventory Gross
InventoryGross
394427 USD
CY2013Q1 us-gaap Assets
Assets
5657634 USD
CY2012Q4 ivda Issuance Of Warrants To Purchase Common Stock One
IssuanceOfWarrantsToPurchaseCommonStockOne
10000 shares
CY2013 us-gaap Interest Expense Debt
InterestExpenseDebt
5000 USD
CY2014Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y
CY2014Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.50
CY2014Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.095 pure
CY2014Q1 ivda Warrant Share Issued
WarrantShareIssued
184045 shares
CY2014Q1 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
1.65
CY2014Q1 ivda Warrant Share Issued For Financing Cost
WarrantShareIssuedForFinancingCost
192424 shares
CY2014Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2024500 USD
CY2014Q1 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
27913 USD
CY2014Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
74645 USD
CY2014Q1 us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P3Y
CY2014Q1 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
11600 USD
CY2014Q1 us-gaap Convertible Debt
ConvertibleDebt
1949855 USD
CY2014Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
175635 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-1505 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-1801 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1257733 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1407369 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-70114 USD
CY2013Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-20058 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-22605 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5693322 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
130000 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
56345 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
127750 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5639227 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4612441 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.44
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.07
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.71
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.10
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.16
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.09
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.33
CY2014Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.10
CY2014Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
1.80
CY2014Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
5639227 shares
CY2014Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y4M24D
CY2014Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.09
CY2014Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
4612441 shares
CY2014Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.33
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2422 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0273 pure
CY2014Q1 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
1 pure
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1405568 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57084 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54324 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
40000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
96000 USD
CY2013Q1 ivda Common Shares Issued For Services
CommonSharesIssuedForServices
13378 USD
CY2014Q1 ivda Common Shares Issued For Services
CommonSharesIssuedForServices
0 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1258084 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
38284 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38197 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66051 USD
CY2013Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-165016 USD
CY2014Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
135472 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-423574 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-23641 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-167937 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1511936 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16656 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
137129 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16656 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-137129 USD
CY2013Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
645511 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-42417 USD
CY2013Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
-313500 USD
CY2014Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2118141 USD
CY2013Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
4600 USD
CY2013Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
64074 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
42000 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5635 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2708172 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1775703 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2009400 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1736 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1592846 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
355105 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114462 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1707308 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
18730 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
32105 USD
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22001587 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26742623 shares
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5230 USD
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Trading Symbol
TradingSymbol
IVDA
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26778357 shares
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
Iveda Solutions, Inc.
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001397183
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-16500 USD
CY2014Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
11600 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
1271083 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1527731 USD
CY2013Q1 ivda Lossfromconversionofdebt
Lossfromconversionofdebt
16500 USD
CY2014Q1 ivda Lossfromconversionofdebt
Lossfromconversionofdebt
-11600 USD
CY2014Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.10
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1500000 USD
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.65
CY2013Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-880 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
19236 USD

Files In Submission

Name View Source Status
0001144204-14-031833-index-headers.html Edgar Link pending
0001144204-14-031833-index.html Edgar Link pending
0001144204-14-031833.txt Edgar Link pending
0001144204-14-031833-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ivda-20140331.xml Edgar Link completed
ivda-20140331.xsd Edgar Link pending
ivda-20140331_cal.xml Edgar Link unprocessable
ivda-20140331_def.xml Edgar Link unprocessable
ivda-20140331_lab.xml Edgar Link unprocessable
ivda-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v378561_10q.htm Edgar Link pending
v378561_ex31-1.htm Edgar Link pending
v378561_ex31-2.htm Edgar Link pending
v378561_ex32-1.htm Edgar Link pending
v378561_ex32-2.htm Edgar Link pending